Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.440 +0.0% GR 0.075 +0.0% AII 20.80 +0.0% TUNG 1.69 +0.0% LGO 1.04 +0.0% EMM 0.080 +0.0% OGN 3.38 +0.0% MSA 6.43 +0.0% SGZ 0.045 +0.0% S 0.120 +0.0% GRSL 0.320 +0.0% DEX 0.385 +0.0% WMS 0.040 +0.0% EMPR 0.820 +0.0% SAGA 0.480 +0.0% ABX 52.22 +0.0% FCI 0.440 +0.0% GR 0.075 +0.0% AII 20.80 +0.0% TUNG 1.69 +0.0% LGO 1.04 +0.0% EMM 0.080 +0.0% OGN 3.38 +0.0% MSA 6.43 +0.0% SGZ 0.045 +0.0% S 0.120 +0.0% GRSL 0.320 +0.0% DEX 0.385 +0.0% WMS 0.040 +0.0% EMPR 0.820 +0.0% SAGA 0.480 +0.0% ABX 52.22 +0.0%
Management Admin

Michael Goettler Resigns from Bausch Health's Board of Directors

By The Northwire Desk — AI Analysis Jul 01, 2026 · 16:15 BHC · 6.99 BAUSCH HEALTH COMPANIES INC.
BHC · Price

Executive Summary

  • Michael Goettler has resigned from the Board of Directors of Bausch Health Companies Inc., effective June 30, 2026.
  • The resignation is due to his appointment as President and Chief Executive Officer of Knoa Pharma LLC.
  • The Board confirmed that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.

Key Details

  • Resigning Director: Michael Goettler
  • Effective Date: June 30, 2026
  • Reason for Resignation: Appointment as President and CEO of Knoa Pharma LLC
  • Board Statement: Chairperson John A. Paulson thanked Mr. Goettler for his service and wished him well in his new role.
  • Disagreement Status: No disagreement with the Company on any matter relating to operations, policies, or practices.

Notable Quotes

  • "We thank Michael for his valued service and wish him the best in his new role," said John A. Paulson, Chairperson of the Bausch Health Board of Directors.
Read the original news release →

More from BAUSCH HEALTH COMPANIES INC.

Jun 09, 2026 · 08:00

Canadian drug plan LOI for PrOKEDI is a steady commercial step, but the stock's -6.5% drift into the print reflects broader pipeline and debt overhangs already discounted.

Regulatory May 28, 2026 · 16:15

Solta Trademark Win Reinforces China Growth Narrative Amidst Elevated Debt Costs and Xifaxan LOE Clock

Production / Operations May 19, 2026 · 16:15

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

Regulatory May 12, 2026 · 16:15

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

Other Apr 29, 2026 · 16:05

BHC Q1 Earnings Mask Pipeline Failure with Core Cash Flow Strength

Earnings Apr 14, 2026 · 08:00

Biafine Launch Fails to Offset Clinical Failure and Debt Burden

Other